animenews: FDA expands use of Gilead's liver drug to rare subset of patients

Affichage des articles dont le libellé est FDA expands use of Gilead's liver drug to rare subset of patients. Afficher tous les articles

mardi 16 février 2016

FDA expands use of Gilead's liver drug to rare subset of patients

(Reuters) - The U.S. Food and Drug Administration has expanded the use of Gilead Sciences Inc's blockbuster drug Harvoni to some hepatitis C patients in the advanced stage of cirrhosis, including those who have undergone liver transplant.

http://ift.tt/1U5HVgy

from Reuters: Health News
via animenewspro

animenews

تعديل

mardi 16 février 2016

FDA expands use of Gilead's liver drug to rare subset of patients

التسميات

أرشيف المدونة الإلكترونية